Medtronic ScreenLink is an evidence based App for quality of care improvement, helping to ensure that access to device therapy provided to heart failure, post-MI and SCA/VF/VT patients is aligned with the latest European, US and UK scientific guidelines.
Medtronic ScreenLink is designed to facilitate screening of patients qualifying for ICD and/or CRT therapies. Healthcare providers who use the ScreenLink app are armed with the latest evidence-based ICD/CRT European, US and UK guidelines gaining immediate access to device therapy decision support. Clinicians and patients can be assured that treatment is aligned with best-practice medicine and is therefore likely to produce improved patient outcomes.
NOTE: patients affected by Brugada or Long-QT syndromes are not evaluated by this system. The ScreenLink app derives from a larger homonimous web application with similar purposes including the ability to link healthcare providers along the clinical patient pathway, enabling improved and more coordinated care.
To learn more http://www.screenlinkcalculator.com/
DISCLAIMER: This application is the copyrighted property of Medtronic. It has been approved by Medtronic only for use with the appropriate Medtronic products. Please contact Medtronic if you wish to use this application for any other purpose. www.medtronic.com